Biography
Biography: Derya T Ata
Abstract
Statement of the problem: Leishmaniasis is a serious neglected tropical disease and nearly 2 million people around the world are at risk of infection. Visceral leishmaniasis is fatal if untreated and most cases occur in Brazil, East Africa and in India. It remains one of the top parasitic diseases with outbreak and mortality potential. At present there is no clinical vaccine for leishmaniasis. Therefore, control is mainly managed by limiting transmission and treating active cases. The purpose of this study was to test a new vaccine candidate in a murine model of visceral leishmaniasis.